Neoplasia III

download Neoplasia III

of 54

Transcript of Neoplasia III

  • 8/12/2019 Neoplasia III

    1/54

  • 8/12/2019 Neoplasia III

    2/54

    Pleomorphic adenoma is benign tumor thatis derived from a mixture of ductal epithelialcells and myoepithelial cells show bothepithelial and mesenchymal differentiation.

    The most common neoplasm of salivaryglands.Location: 60% of tumors in the parotid, lesscommon in the submandibular glands, &

    relatively rare in the minor salivary glands. Inparotid gland, most tumor arise within thesuperficial lobe.Sex & Age: frequent in women in the 4 th

    decade of life. But it can be occurred inchildren & in elderly persons of either sex.

  • 8/12/2019 Neoplasia III

    3/54

    Symptoms: painless, slow growing, mobilediscrete mass within the parotid orsubmadibular areas or in the buccal cavity.Treatment: parotidectomy.Recurrence: 4% (parotidectomy) 25%(enucleation).

  • 8/12/2019 Neoplasia III

    4/54

    Rounded and well demarcated mass.Encapsulated (but sometimes the capsule isnot fully developed producing a tongue-likeprotrusions into the surrounding gland)Cut Section: solid, gray white in color,consistency depends on the relative amountof epithelial cells and stroma.

  • 8/12/2019 Neoplasia III

    5/54

  • 8/12/2019 Neoplasia III

    6/54

    Tumor composed of two components(biphasic appearance): Epithelial component

    Forming duct structures / acini / irregular tubules /

    sheets of cells.Foci of squamous metaplasia are common. Mesenchymal component

    Loose myxoid tissue (contained stellate cells)Cartilagenous or osseus differentiation are usually

    found

  • 8/12/2019 Neoplasia III

    7/54

  • 8/12/2019 Neoplasia III

    8/54

  • 8/12/2019 Neoplasia III

    9/54

  • 8/12/2019 Neoplasia III

    10/54

  • 8/12/2019 Neoplasia III

    11/54

  • 8/12/2019 Neoplasia III

    12/54

  • 8/12/2019 Neoplasia III

    13/54

  • 8/12/2019 Neoplasia III

    14/54

    The most common benign tumor of thefemale breast.Age: reproductive period.Frequently multiple & bilateral.Symptoms: palpable mass, painless andmobile.

  • 8/12/2019 Neoplasia III

    15/54

    Spherical noduleSolidFirm and rubbery

    Well demarcated pseudocapsuleGray white

  • 8/12/2019 Neoplasia III

    16/54

  • 8/12/2019 Neoplasia III

    17/54

  • 8/12/2019 Neoplasia III

    18/54

    The tumor consisted of ductularproliferation and proliferation offibromyxomatic stroma. Proliferation of ductuli may form a slit-like (called

    intracanalicular) or round spaces (calledpericanalicular)

    The fibromyxomatic stroma contain spindle andstellate cells.

  • 8/12/2019 Neoplasia III

    19/54

  • 8/12/2019 Neoplasia III

    20/54

  • 8/12/2019 Neoplasia III

    21/54

  • 8/12/2019 Neoplasia III

    22/54

  • 8/12/2019 Neoplasia III

    23/54

  • 8/12/2019 Neoplasia III

    24/54

    COMMON SOLID TUMOR OF CHILDHOOD,90% FOUND BEFORE AGE 6 ,PEAK AGES 2 TO5.PRESENT WITH AN ABDOMINAL MASS ORABDOMINAL TENDERNESS, MAY PRESENTWITH HEMATURIA,HYPERTENSION OR WITHPERITONEAL SYMPTOMS.

    PROGNOSIS DEPEND ON TUMORSTAGE,HISTOLOGIC FEATURES & PATIENTAGE AT TIME OF DIAGNOSIS.

  • 8/12/2019 Neoplasia III

    25/54

    TYPICALLY SINGLE,WELL CIRCUM-SCRIBEDMASS WITH LOBULATED APPEARANCE.VARIEGATED,BULGING MASS,PALE GRAY TOTAN-PINK,CUT SURFACE : TYPICALLY WITH EXTENSIVEHEMORRHAGE & NECROSIS, CYSTFORMATION MAY BE SEEN.

  • 8/12/2019 Neoplasia III

    26/54

  • 8/12/2019 Neoplasia III

    27/54

    CLASSICALLY SHOWED TRIPHASICAPPEARANCE CONSISTED OFBLASTEMA,STROMAL & EPITELIALCOMPONENT.BLASTEMAL COMPONENT IS ARRANGED IN

    DIFFUSED SHEETS,THIN CORDS OR ASNODULAR AGGREGATS,PERIPHERALPALISADING OF NUCLEI MAY BE SEEN.BLASTEMA COMPOSED OF SMALL ROUND

    CELL WITH HYPERCHROMATIC NUCLEI,COARSE CHROMATIN & SCANTYCYTOPLASM

  • 8/12/2019 Neoplasia III

    28/54

    STROMA IS TYPICALLY

    MYXOID/FIBROMYXOID,DIFFERENTIATIONTOWARD SKELETAL MUSCLE OR LESSCOMMONLY CARTILAGE, BONE, FAT,NEURAL TISSUE MAY BE SEEN.

    EPITHELIAL COMPONENT IS IN THE FORM OFPOORLY FORMED TUBULES & GROMERULAR(TUBULAR,GROMERULAR ABORTIVE)

  • 8/12/2019 Neoplasia III

    29/54

  • 8/12/2019 Neoplasia III

    30/54

  • 8/12/2019 Neoplasia III

    31/54

  • 8/12/2019 Neoplasia III

    32/54

  • 8/12/2019 Neoplasia III

    33/54

    DERMOID CYST

  • 8/12/2019 Neoplasia III

    34/54

    This tumor is presumably derived from theectodermal differentiation of totipotentialcells.Cystic teratomas are usually found in youngwomen during the active reproductive years.Bilateral in 10% 15% cases.

  • 8/12/2019 Neoplasia III

    35/54

    Cystic tumor, usually unilocular.Containing hair and cheesy sebaceousmaterial.Cut section: Thin wall cystic tumor, with fociof thickened wall where hair shafts frequentlyprotude (called: Dermal Plaque).

  • 8/12/2019 Neoplasia III

    36/54

  • 8/12/2019 Neoplasia III

    37/54

  • 8/12/2019 Neoplasia III

    38/54

  • 8/12/2019 Neoplasia III

    39/54

  • 8/12/2019 Neoplasia III

    40/54

    Cystic tumors, lined by stratified squamousepithelium with underlying skin adnexae suchas: sebaceous glands, hair shafts, lipid cells,etc.Structures from other germ layer can beidentified, such as: cartilage, bone, thyroidtissue, GI tract mucosal tissue, bronchus,nerve, glial tissue, etc.

  • 8/12/2019 Neoplasia III

    41/54

  • 8/12/2019 Neoplasia III

    42/54

  • 8/12/2019 Neoplasia III

    43/54

  • 8/12/2019 Neoplasia III

    44/54

  • 8/12/2019 Neoplasia III

    45/54

  • 8/12/2019 Neoplasia III

    46/54

    Solid, lobulated.Greyish white.Infrequent necrotic

    and hemorrhageareasGenerally does notinfiltrate to thetunica albuginea.

  • 8/12/2019 Neoplasia III

    47/54

  • 8/12/2019 Neoplasia III

    48/54

    Tumor cells are large size, round topolyhedral shape. Round, large, centrallocated nuclei, conspicuous nucleoli, clearcytoplasm and distinct cell membrane.

    Tumor cells divided into poorly demarcatedlobules by delicate septa and interveninglymphoid stroma.

  • 8/12/2019 Neoplasia III

    49/54

  • 8/12/2019 Neoplasia III

    50/54

  • 8/12/2019 Neoplasia III

    51/54

  • 8/12/2019 Neoplasia III

    52/54

  • 8/12/2019 Neoplasia III

    53/54

  • 8/12/2019 Neoplasia III

    54/54